2025 |
Nurix Therapeutics Inc
|
Director |
- |
- |
2024 |
Travere Therapeutics Inc
|
Independent Director |
247.3 K |
- |
2024 |
Aardvark Therapeutics Inc.
|
Independent Director |
171.4 K |
- |
2024 |
Nurix Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
Natera Inc
|
Independent Director |
- |
- |
2023 |
Natera Inc
|
Independent Director |
317.7 K |
-19.2 % |
2023 |
Travere Therapeutics Inc
|
Independent Director |
- |
- |
2022 |
Natera Inc
|
Independent Director |
393.3 K |
17.7 % |
2022 |
Atara Biotherapeutics Inc
|
Independent Director |
352.8 K |
-0.9 % |
2022 |
Travere Therapeutics Inc
|
Independent Director |
321.6 K |
13.1 % |
2022 |
Atara Biotherapeutics Inc
|
Independent Director |
- |
- |
2021 |
Atara Biotherapeutics Inc
|
Independent Director |
356.0 K |
17.3 % |
2021 |
Natera Inc
|
Independent Director |
334.1 K |
7.1 % |
2021 |
Travere Therapeutics Inc
|
Independent Director |
284.2 K |
13.6 % |
2020 |
Natera Inc
|
Independent Director |
311.9 K |
-3.4 % |
2020 |
Atara Biotherapeutics Inc
|
Independent Director |
303.5 K |
3.4 % |
2020 |
Travere Therapeutics Inc
|
Independent Director |
250.2 K |
2.9 % |
2019 |
Natera Inc
|
Independent Director |
322.9 K |
26.3 % |
2019 |
Atara Biotherapeutics Inc
|
Independent Director |
293.6 K |
-28.6 % |
2019 |
Travere Therapeutics Inc
|
Independent Director |
243.2 K |
-37.9 % |
2018 |
Atara Biotherapeutics Inc
|
Independent Director |
411.5 K |
- |
2018 |
Travere Therapeutics Inc
|
Independent Director |
391.5 K |
86.0 % |
2018 |
Natera Inc
|
Independent Director |
255.6 K |
- |
2017 |
Travere Therapeutics Inc
|
Independent Director |
210.5 K |
-16.1 % |
2016 |
Travere Therapeutics Inc
|
Independent Director |
250.9 K |
- |